News Release

Telemedicine versus office-based follow-up after meniscal surgery: Trial shows 'equivalent' patient satisfaction scores

Peer-Reviewed Publication

Wolters Kluwer Health

March 15, 2021 - After arthroscopic surgery on the meniscus of the knee, patients using telemedicine for postoperative follow-up are just as satisfied with their care as those making in-person visits, reports a study in The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.

"Patient satisfaction with overall care is equivalent between telemedicine and office-based follow-up after an arthroscopic meniscal surgical procedure in the immediate postoperative period," according to the randomized trial report by Christina P. Herrero, MD, and colleagues of NYU Langone Health, New York , and colleagues.

Telemedicine is 'a reasonable alternative' for postoperative visits

The study included 122 patients who underwent arthroscopic surgery of the meniscus - sometimes called the "shock absorber" of the knee. About 88 percent of patients underwent removal of the meniscus (meniscectomy), and the rest underwent meniscal repair procedures. Arthroscopic meniscal surgery is one of the most common orthopaedic surgical procedures.

Patients were randomly assigned to either office-based or telemedicine follow-up, scheduled for 5 to 14 days postoperatively. During both types of follow-up visits, the surgeon talked to the patient about the surgical findings, the patient's pain, and the postoperative recovery period and performed a physical examination that included range-of-motion testing.

Of course, surgeons could not feel or touch the knee during telemedicine follow-ups - but they were still able to perform a visual assessment of wound healing, drainage, and swelling. Telemedicine follow-ups were performed using the patient's home computer or mobile device via a telemedicine program that was compliant with privacy rules.

In patient surveys, overall satisfaction ratings were almost identical between groups. Average patient satisfaction scores (on a 0-to-10 scale) were 9.77 with office-based follow-up and 9.79 for telemedicine follow-up. In both groups, only about 20 percent of patients said they would have preferred the other type of visit. Pain scores also showed similar improvement between groups: from about 5 (out of 10) on the day of the surgery to 3 at the follow-up visit.

Both groups had low complication rates. Two patients in each group had pain and swelling, raising concern about a possible blood clot-related complication (venous thromboembolism, or VTE). All four patients were sent for same-day Doppler ultrasound scans, which found no evidence of VTE. "All potential complications were identified, and there were no subsequent or missed complications identified on subsequent chart review," Dr. Herrero and colleagues write.

Telemedicine is a promising approach to delivering "direct, long-range care" to patients with many different conditions. During the COVID-19 pandemic, the use of telemedicine in routine medical care has greatly accelerated; the researchers began their study well before the start of the pandemic.

Although studies have reported a wide range of benefits from telemedicine visits, there are mixed data regarding satisfaction with telemedicine visits among patients undergoing common orthopaedic procedures. The new study is the first to directly compare telemedicine with standard office-based follow-up after orthopaedic surgery.

"Telemedicine may be a reasonable alternative to office-based follow-up after knee arthroscopy," Dr. Herrero and coauthors conclude. "[Our] study only evaluated the first postoperative visit, but future studies may benefit from expanding the use of telemedicine to longer-term follow-ups or to additional surgical procedures."


Click here to read "Patient Satisfaction Is Equivalent Using Telemedicine Versus Office-Based Follow-up After Arthroscopic Meniscal Surgery."
DOI: 10.2106/JBJS.20.01413

About The Journal of Bone & Joint Surgery

The Journal of Bone & Joint Surgery (JBJS) has been the most valued source of information for orthopaedic surgeons and researchers for over 125 years and is the gold standard in peer-reviewed scientific information in the field. A core journal and essential reading for general as well as specialist orthopaedic surgeons worldwide, The Journal publishes evidence-based research to enhance the quality of care for orthopaedic patients. Standards of excellence and high quality are maintained in everything we do, from the science of the content published to the customer service we provide. JBJS is an independent, non-profit journal.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit, follow us on Twitter, Facebook, LinkedIn, and YouTube.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.